位置:首页 > 蛋白库 > S10A3_HUMAN
S10A3_HUMAN
ID   S10A3_HUMAN             Reviewed;         101 AA.
AC   P33764; D3DV51; Q6FGE4;
DT   01-FEB-1994, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1994, sequence version 1.
DT   03-AUG-2022, entry version 193.
DE   RecName: Full=Protein S100-A3;
DE   AltName: Full=Protein S-100E;
DE   AltName: Full=S100 calcium-binding protein A3;
GN   Name=S100A3; Synonyms=S100E;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA].
RX   PubMed=8341667; DOI=10.1073/pnas.90.14.6547;
RA   Engelkamp D., Schaefer B.W., Mattei M.-G., Erne P., Heizmann C.W.;
RT   "Six S100 genes are clustered on human chromosome 1q21: identification of
RT   two genes coding for the two previously unreported calcium-binding proteins
RT   S100D and S100E.";
RL   Proc. Natl. Acad. Sci. U.S.A. 90:6547-6551(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Halleck A., Ebert L., Mkoundinya M., Schick M., Eisenstein S., Neubert P.,
RA   Kstrang K., Schatten R., Shen B., Henze S., Mar W., Korn B., Zuo D., Hu Y.,
RA   LaBaer J.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   CHARACTERIZATION.
RX   PubMed=9920417; DOI=10.1016/s0167-4889(98)00138-4;
RA   Fritz G., Heizmann C.W., Kroneck P.M.H.;
RT   "Probing the structure of the human Ca2+- and Zn2+-binding protein S100A3:
RT   spectroscopic investigations of its transition metal ion complexes, and
RT   three-dimensional structural model.";
RL   Biochim. Biophys. Acta 1448:264-276(1998).
RN   [8]
RP   CLEAVAGE OF INITIATOR METHIONINE, ACETYLATION AT ALA-2, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=12470658; DOI=10.1016/s0006-291x(02)02744-4;
RA   Kizawa K., Troxler H., Kleinert P., Inoue T., Toyoda M., Morohashi M.,
RA   Heizmann C.W.;
RT   "Characterization of the cysteine-rich calcium-binding S100A3 protein from
RT   human hair cuticles.";
RL   Biochem. Biophys. Res. Commun. 299:857-862(2002).
RN   [9]
RP   FUNCTION, SUBUNIT, CITRULLINATION AT ARG-51, AND SUBCELLULAR LOCATION.
RX   PubMed=18083705; DOI=10.1074/jbc.m709357200;
RA   Kizawa K., Takahara H., Troxler H., Kleinert P., Mochida U., Heizmann C.W.;
RT   "Specific citrullination causes assembly of a globular S100A3 homotetramer:
RT   a putative Ca2+ modulator matures human hair cuticle.";
RL   J. Biol. Chem. 283:5004-5013(2008).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS).
RX   PubMed=12136135; DOI=10.1107/s0907444902008430;
RA   Mittl P.R., Fritz G., Sargent D.F., Richmond T.J., Heizmann C.W.,
RA   Grutter M.G.;
RT   "Metal-free MIRAS phasing: structure of apo-S100A3.";
RL   Acta Crystallogr. D 58:1255-1261(2002).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (1.45 ANGSTROMS), DISULFIDE BONDS, ZINC-BINDING
RP   SITES, AND MUTAGENESIS OF CYS-30; CYS-68; CYS-81 AND CYS-99.
RX   PubMed=21377473; DOI=10.1016/j.jmb.2011.02.055;
RA   Unno M., Kawasaki T., Takahara H., Heizmann C.W., Kizawa K.;
RT   "Refined crystal structures of human Ca(2+)/Zn(2+)-binding S100A3 protein
RT   characterized by two disulfide bridges.";
RL   J. Mol. Biol. 408:477-490(2011).
CC   -!- FUNCTION: Binds both calcium and zinc. May be involved in calcium-
CC       dependent cuticle cell differentiation, hair shaft and hair cuticular
CC       barrier formation. {ECO:0000269|PubMed:18083705}.
CC   -!- SUBUNIT: Homodimer and homotetramer for the citrullinated form.
CC       {ECO:0000269|PubMed:18083705}.
CC   -!- INTERACTION:
CC       P33764; Q8TBB1: LNX1; NbExp=3; IntAct=EBI-1044747, EBI-739832;
CC       P33764; P23297: S100A1; NbExp=3; IntAct=EBI-1044747, EBI-743686;
CC       P33764; P60903: S100A10; NbExp=3; IntAct=EBI-1044747, EBI-717048;
CC       P33764; P29034: S100A2; NbExp=5; IntAct=EBI-1044747, EBI-752230;
CC       P33764; Q8WXG8: S100Z; NbExp=3; IntAct=EBI-1044747, EBI-12198403;
CC       P33764; P04637: TP53; NbExp=2; IntAct=EBI-1044747, EBI-366083;
CC       P33764; Q8TD43: TRPM4; NbExp=2; IntAct=EBI-1044747, EBI-11723041;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:18083705}.
CC   -!- TISSUE SPECIFICITY: Skin specific, specifically expressed at the inner
CC       endocuticle of hair fibers. {ECO:0000269|PubMed:12470658}.
CC   -!- PTM: More than half of the arginine residues undergo citrullination by
CC       PAD1 and PAD2. Arg-51 is specifically citrullinated by PAD3 and
CC       promotes tetramerization. {ECO:0000269|PubMed:18083705}.
CC   -!- SIMILARITY: Belongs to the S-100 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Z18948; CAA79471.1; -; mRNA.
DR   EMBL; Z18950; CAA79473.1; -; Genomic_DNA.
DR   EMBL; BT006955; AAP35601.1; -; mRNA.
DR   EMBL; CR542163; CAG46960.1; -; mRNA.
DR   EMBL; CR542185; CAG46982.1; -; mRNA.
DR   EMBL; BX470102; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471121; EAW53306.1; -; Genomic_DNA.
DR   EMBL; CH471121; EAW53307.1; -; Genomic_DNA.
DR   EMBL; BC012893; AAH12893.1; -; mRNA.
DR   CCDS; CCDS1043.1; -.
DR   PIR; C48219; C48219.
DR   PIR; S70326; S70326.
DR   RefSeq; NP_002951.1; NM_002960.1.
DR   PDB; 1KSO; X-ray; 1.70 A; A/B=1-101.
DR   PDB; 3NSI; X-ray; 2.15 A; A/B=1-101.
DR   PDB; 3NSK; X-ray; 1.55 A; A/B=1-101.
DR   PDB; 3NSL; X-ray; 1.50 A; A/B/C/D/E/F=2-101.
DR   PDB; 3NSO; X-ray; 1.45 A; A/B=1-101.
DR   PDBsum; 1KSO; -.
DR   PDBsum; 3NSI; -.
DR   PDBsum; 3NSK; -.
DR   PDBsum; 3NSL; -.
DR   PDBsum; 3NSO; -.
DR   AlphaFoldDB; P33764; -.
DR   SMR; P33764; -.
DR   BioGRID; 112182; 74.
DR   IntAct; P33764; 23.
DR   STRING; 9606.ENSP00000357702; -.
DR   iPTMnet; P33764; -.
DR   BioMuta; S100A3; -.
DR   DMDM; 464729; -.
DR   EPD; P33764; -.
DR   jPOST; P33764; -.
DR   MassIVE; P33764; -.
DR   MaxQB; P33764; -.
DR   PaxDb; P33764; -.
DR   PeptideAtlas; P33764; -.
DR   PRIDE; P33764; -.
DR   ProteomicsDB; 54924; -.
DR   Antibodypedia; 20380; 238 antibodies from 31 providers.
DR   DNASU; 6274; -.
DR   Ensembl; ENST00000368712.1; ENSP00000357701.1; ENSG00000188015.10.
DR   Ensembl; ENST00000368713.8; ENSP00000357702.3; ENSG00000188015.10.
DR   GeneID; 6274; -.
DR   KEGG; hsa:6274; -.
DR   MANE-Select; ENST00000368713.8; ENSP00000357702.3; NM_002960.2; NP_002951.1.
DR   UCSC; uc001fca.2; human.
DR   CTD; 6274; -.
DR   DisGeNET; 6274; -.
DR   GeneCards; S100A3; -.
DR   HGNC; HGNC:10493; S100A3.
DR   HPA; ENSG00000188015; Tissue enhanced (skin).
DR   MIM; 176992; gene.
DR   neXtProt; NX_P33764; -.
DR   OpenTargets; ENSG00000188015; -.
DR   PharmGKB; PA34905; -.
DR   VEuPathDB; HostDB:ENSG00000188015; -.
DR   eggNOG; ENOG502SSQB; Eukaryota.
DR   GeneTree; ENSGT00940000161959; -.
DR   HOGENOM; CLU_138624_2_0_1; -.
DR   InParanoid; P33764; -.
DR   OMA; CVYCHEY; -.
DR   OrthoDB; 1513264at2759; -.
DR   PhylomeDB; P33764; -.
DR   TreeFam; TF332727; -.
DR   PathwayCommons; P33764; -.
DR   SignaLink; P33764; -.
DR   BioGRID-ORCS; 6274; 11 hits in 1064 CRISPR screens.
DR   ChiTaRS; S100A3; human.
DR   EvolutionaryTrace; P33764; -.
DR   GeneWiki; S100A3; -.
DR   GenomeRNAi; 6274; -.
DR   Pharos; P33764; Tbio.
DR   PRO; PR:P33764; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; P33764; protein.
DR   Bgee; ENSG00000188015; Expressed in lower esophagus mucosa and 108 other tissues.
DR   Genevisible; P33764; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:HPA.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0005509; F:calcium ion binding; IBA:GO_Central.
DR   GO; GO:0048306; F:calcium-dependent protein binding; IBA:GO_Central.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   CDD; cd00213; S-100; 1.
DR   InterPro; IPR011992; EF-hand-dom_pair.
DR   InterPro; IPR034325; S-100_dom.
DR   InterPro; IPR001751; S100/CaBP7/8-like_CS.
DR   InterPro; IPR013787; S100_Ca-bd_sub.
DR   InterPro; IPR028488; S100A3.
DR   PANTHER; PTHR11639:SF12; PTHR11639:SF12; 1.
DR   Pfam; PF01023; S_100; 1.
DR   SMART; SM01394; S_100; 1.
DR   SUPFAM; SSF47473; SSF47473; 1.
DR   PROSITE; PS00303; S100_CABP; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Calcium; Citrullination; Cytoplasm;
KW   Disulfide bond; Metal-binding; Reference proteome; Repeat; Zinc.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|PubMed:12470658"
FT   CHAIN           2..101
FT                   /note="Protein S100-A3"
FT                   /id="PRO_0000143972"
FT   DOMAIN          12..47
FT                   /note="EF-hand 1"
FT   DOMAIN          50..85
FT                   /note="EF-hand 2"
FT   BINDING         28
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /ligand_note="low affinity"
FT                   /evidence="ECO:0000255"
FT   BINDING         33
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /ligand_note="low affinity"
FT                   /evidence="ECO:0000255"
FT   BINDING         63
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /ligand_note="high affinity"
FT                   /evidence="ECO:0000255"
FT   BINDING         65
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /ligand_note="high affinity"
FT                   /evidence="ECO:0000255"
FT   BINDING         67
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /ligand_note="high affinity"
FT                   /evidence="ECO:0000255"
FT   BINDING         69
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /ligand_note="high affinity"
FT                   /evidence="ECO:0000255"
FT   BINDING         74
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /ligand_note="high affinity"
FT                   /evidence="ECO:0000255"
FT   BINDING         83
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT   BINDING         86
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT   BINDING         87
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT   BINDING         93
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000269|PubMed:12470658"
FT   MOD_RES         51
FT                   /note="Citrulline; by PAD3"
FT                   /evidence="ECO:0000269|PubMed:18083705"
FT   DISULFID        30..68
FT                   /evidence="ECO:0000269|PubMed:21377473"
FT   DISULFID        81..99
FT                   /evidence="ECO:0000269|PubMed:21377473"
FT   VARIANT         3
FT                   /note="R -> K (in dbSNP:rs36022742)"
FT                   /id="VAR_061047"
FT   MUTAGEN         30
FT                   /note="C->A: Abolishes calcium binding; when associated
FT                   with Ala-68."
FT                   /evidence="ECO:0000269|PubMed:21377473"
FT   MUTAGEN         68
FT                   /note="C->A: Abolishes calcium binding; when associated
FT                   with Ala-30."
FT                   /evidence="ECO:0000269|PubMed:21377473"
FT   MUTAGEN         81
FT                   /note="C->A: Increases affinity for calcium; when
FT                   associated with Ala-99."
FT                   /evidence="ECO:0000269|PubMed:21377473"
FT   MUTAGEN         99
FT                   /note="C->A: Increases affinity for calcium; when
FT                   associated with Ala-81."
FT                   /evidence="ECO:0000269|PubMed:21377473"
FT   HELIX           4..20
FT                   /evidence="ECO:0007829|PDB:3NSO"
FT   STRAND          22..24
FT                   /evidence="ECO:0007829|PDB:1KSO"
FT   STRAND          28..30
FT                   /evidence="ECO:0007829|PDB:3NSL"
FT   HELIX           31..41
FT                   /evidence="ECO:0007829|PDB:3NSO"
FT   TURN            42..44
FT                   /evidence="ECO:0007829|PDB:3NSO"
FT   TURN            49..51
FT                   /evidence="ECO:0007829|PDB:3NSK"
FT   HELIX           52..64
FT                   /evidence="ECO:0007829|PDB:3NSO"
FT   TURN            65..67
FT                   /evidence="ECO:0007829|PDB:3NSL"
FT   STRAND          68..71
FT                   /evidence="ECO:0007829|PDB:3NSL"
FT   HELIX           72..86
FT                   /evidence="ECO:0007829|PDB:3NSO"
FT   HELIX           88..90
FT                   /evidence="ECO:0007829|PDB:3NSO"
SQ   SEQUENCE   101 AA;  11713 MW;  ABCAF4B7E5F2E0A1 CRC64;
     MARPLEQAVA AIVCTFQEYA GRCGDKYKLC QAELKELLQK ELATWTPTEF RECDYNKFMS
     VLDTNKDCEV DFVEYVRSLA CLCLYCHEYF KDCPSEPPCS Q
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024